Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 3.

Hauschild, Axel; Dummer, Reinhard; Schadendorf, Dirk; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry; Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal, Eduard; Kefford, Richard; Kirkwood, John M; Long, Georgina V (2018). Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma. Journal of Clinical Oncology:JCO1801219.

Long, Georgina V; Hauschild, Axel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew; Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Schadendorf, Dirk; Lesimple, Thierry; Plummer, Ruth; Ji, Ran; Zhang, Pingkuan; Mookerjee, Bijoyesh; Legos, Jeff; Kefford, Richard; Dummer, Reinhard; Kirkwood, John M (2017). Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. New England Journal of Medicine, 377(19):1813-1823.

Xue, Gongda; Kohler, Reto; Tang, Fengyuan; Hynx, Debby; Wang, Yuhua; Orso, Francesca; Prêtre, Vincent; Ritschard, Reto; Hirschmann, Petra; Cron, Peter; Roloff, Tim; Dummer, Reinhard; Mandalà, Mario; Bichet, Sandrine; Genoud, Christel; Meyer, Alexandra G; Muraro, Manuele G; Spagnoli, Giulio C; Taverna, Daniela; Rüegg, Curzio; Merghoub, Taha; Massi, Daniela; Tang, Huifang; Levesque, Mitchell P; Dirnhofer, Stephan; Zippelius, Alfred; Hemmings, Brian A; Wicki, Andreas (2017). mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition. OncoTarget, 8(41):69204-69218.

This list was generated on Fri May 24 09:29:34 2019 CEST.